All-Season Containment Approach Maintains Product Integrity Even At Extreme Temperatures

Talecris Biotherapeutics is a new company proud to inherit a legacy of more than 60 years of providing lifesaving and life-enhancing plasma-derived therapeutic proteins through the acquired assets of Bayer Biological Products’ plasma business.

Talecris is recognized as one of the world’s leading producers of innovative products, starting with the development of albumin and continuing with other products for immune deficiencies, genetic lung disease, hemophilia, and passive immunity. Talecris is now uniquely positioned to create a new standard of excellence in the field of biotherapeutics.

The increased pressure to ensure cold chain integrity has made developing and controlling shipping conditions a top priority for pharmaceutical manufacturers.